chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Palpitations; losing feeling on the left side of her face, neck, shoulder, chest, arm and hand; Tingling; the patient ALMOST went into cardiac arrest; blood pressure was 168/102; Itching in arm; Swelling in arm; This case was reported by a consumer via call center representative and described the occurrence of cardiac arrest in a 54-year-old female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Concurrent medical conditions included latex allergy (she was allergic to latex) and allergy (was allergic to several ingredients and would like to know what ingredients were in the vaccine).   On 17th September 2021, the patient received Boostrix. On 17th September 2021 14:00, less than a day after receiving Boostrix, the patient experienced itchy upper limbs and swelling arm. On 18th September 2021, the patient experienced cardiac arrest (serious criteria GSK medically significant) and blood pressure high. On 18th September 2021 10:00, the patient experienced loss of sensation and tingling. On an unknown date, the patient experienced palpitation. On an unknown date, the outcome of the cardiac arrest, loss of sensation, tingling and itchy upper limbs were unknown and the outcome of the blood pressure high and swelling arm were recovered/resolved and the outcome of the palpitation was not recovered/not resolved.   It was unknown if the reporter considered the cardiac arrest, blood pressure high, loss of sensation, tingling, itchy upper limbs, swelling arm and palpitation to be related to Boostrix.   Additional details were reported as follows: This case was reported by the patient for herself. The patient was unsure whether the Boostrix vaccine administered in left arm to her was from a vial or if it was a pre-filled syringe. The patient was rushed to urgent care after receiving the Boostrix vaccine. The patient reported that she had swelling and itching in her arm at 2 pm on the same day of vaccination.  The patient reported that at 10 am on 18th September 2021, 1 day after receiving vaccination, she experienced tingling and was losing feeling on the left side of her face, neck, shoulder, chest, arm and hand. 1 day after receiving vaccination, the patient reported that she went into cardiac arrest, and her blood pressure was 168/102 mmHg. The patient confirmed that she went to urgent care and was not admitted to the hospital on 18th September 2021. The patient reported that tests were done including EKG (electrocardiogram) and chest x-ray. Less than 2 months after vaccination, the patient reported that she still had palpitations. The patient reported that she had an appointment in November 2021 for a stress test and would have a heart monitor for two weeks. The patient did not have Lot number or expiry date of vaccine. The patient went again to urgent care on 18th October 2021 with same symptoms. The reporter consented to follow-up.
Lump under armpit; This is a spontaneous report from a contactable pharmacist from a Pfizer-sponsored program . A 16-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm on 15May2021 10:46 (Batch/Lot Number: EW0182; Expiration Date: 31Aug2021) as single dose for COVID-19 immunisation. Patient's Medical History (including any illness at time of vaccination) was none. There were no concomitant medications. No additional vaccines administered on same date of the Pfizer suspect. The patient did not receive prior Vaccinations (within 4 weeks). And had no AE(s) following prior vaccinations. Family Medical History Relevant to AE(s) was unknown. About a week after first dose (May2021) of Covid-19 vaccine administered on 15May2021, the patient developed the lump under her armpit. AE(s) did not require a visit to Emergency Room/ Physician Office. The patient wanted to know the treatment for this lump. The reporter did not know if the lump under the patient's armpit had improved, persisted, or worsened. Reporter assessed the event as non-serious. There were no Investigation assessment and no relevant tests. Outcome of the event was unknown. The reporter assessed the relatedness of drug to reaction(s)/event(s) by Global Introspection method as Related.
local swelling lt arm @ site of inject of MMR & 2mm" pimple like lesion also on arm & back & face, rt cheek;
Migraine headache that persisted the entire day. Took a Bayer Back & Body Extra Strength (500mg) to attempt to get rid of itarround noon. Headache only lessened slightly but persisted. Cold chills began in the late afternoon and persisted into the evening. No fever was detected when checked. Took a second Bayer Back & Body Extra Strength around 8pm before bed. Fell asleep about 10pm. Woke up with alarm at 2am. Clothes had a feeling of having absorbed a cold sweet while asleep. Cold chills no longer present, migraine headache no longer present.
Case number PHHY2011AR50356 is an initial spontaneous report from Health Authority (Ministry of health) on 07 Jun 2011: This report refers to a 22-year-old female patient. She received FLUVIRIN (batch number not reported). On an unknown date, she presented with spontaneous abortion. After ultrasound, diagnosis was made as retained dead fetus syndrome.
Patient reported to the pharmacy on 5-7-2021 stating that his arm developed a red rash on 5-6-2021 after receiving his second vaccination on 5-4-2021 .  Upon examination, the rash extended from the upper arm down to just above the elbow of the left arm.  Patient reported the red rash as "achy" and that he wanted to  make sure he was reporting the reaction appropriately.  The rash did not feel warmer than other regions of the arm and was not itchy.
Vaccine administered  (on day 32)/Vial was kept between 36 and 45.9 degrees Fahrenheit; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD (on day 32)/Vial was kept between 36 and 45.9 degrees Fahrenheit) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD (on day 32)/Vial was kept between 36 and 45.9 degrees Fahrenheit). On 16-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered BUD (on day 32)/Vial was kept between 36 and 45.9 degrees Fahrenheit) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   NO concomitant medications provided. NO treatment information provided .   Most recent FOLLOW-UP information incorporated above includes: On 02-Oct-2021: F/U received on 04-OCT-2021 includes dose 1 information
Pt experienced a temperature of 101 - 102 that started 2 days post vax and lasted for 5 days. Pt also had scattered red rash all over body starting 3 days post vax, with loose stools for 4 days, decreased appetite for solids, increased fluid intake. Pt treated with Benadryl for pruritus and Tylenol for fever.
headache; chills; slight sore throat; body ache; loose stools; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 21-year-old female patient received BNT162B2 (PFIZER COVID-19 VACCINE) (Batch/Lot number: unknown) at the age of 21 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (Dose 1 (Lot Number: Not provided)), for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious), outcome "recovered", described as "headache"; CHILLS (non-serious), outcome "recovered", described as "chills"; OROPHARYNGEAL PAIN (non-serious), outcome "recovered", described as "slight sore throat"; PAIN (non-serious), outcome "recovered", described as "body ache"; DIARRHOEA (non-serious), outcome "unknown", described as "loose stools".  Additional Information: The patient received the second dose around 10:30 AM. At 20:00, she started to have a headache. At 22:00, she experienced chills. The next morning, she had a headache, slight sore throat, and body ache. These resolved by that afternoon. The next day, she experienced loose stools.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a physician referring to a 60 year old female patient. The patient's pertinent medical history, concurrent conditions, concomitant therapies and drug/allergies reactions were not reported. On 14-DEC-2016, the patient was vaccinated with a dose of ZOSTAVAX 19400 PUF (dose, route, lot # and expiration date were not reported) for prophylaxis. On an unknown date, in December 2016, the patient experienced fever, injection site swelling and injection site erythema. The reporter stated that patient went to emergency on an unspecified date and was treated with KEFLEX 500 mg 3 times daily and prednisone (manufacturer unknown) 50mg orally one time daily. The physician reported that on 18-DEC-2016, due to lack of improvement, KEFLEX was stopped and doxycycline (manufacturer unknown) 100 mg twice daily was started. The physician reported that the patient's arm looks better (injection site swelling and injection site erythema were recovering), however nausea, pyrexia, and itching (pruritus) developed, on an unspecified date in December 2016. The outcome of pruritus, nausea and pyrexia was reported as not recovered. The relationship between the aforementioned events and ZOSTAVAX was not established or mentioned by he reporter. Additional information has been requested.
Patient came to the pharmacy today and said that his arm was very sore from the two immunizations I gave him yesterday. Upon examination, there was slight swelling from the deltoid down onto the tricep. The upper arm was warm to the touch, but no redness was visible. He was showing no signs of an allergic reaction. I told him to ice it overnight and I would follow up with him on my next work day.
0.5 ml Moderna covid vaccine administered in right deltoid at 0630. Several minutes following vaccine c/o feeling flushed and "really hot." She was hypertensive and tachycardic throughout the monitoring period following vaccine. She c/o headache, nausea, hot and cold, flushed, noted blotchy skin and shaking hands (noted prior to vaccine) Evaluated by Dr. Husband called to transport home. Instructed when to return to ED
Severe nerve pain in left hip and left lower abdomen.; Felt like deep burning pain; This spontaneous case was reported by an other health care professional and describes the occurrence of NEURALGIA (Severe nerve pain in left hip and left lower abdomen.) and PAIN (Felt like deep burning pain) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     Concurrent medical conditions included Cytogenetic abnormality (genetic deletions 15q11.21, 16p, 2p16.3 found when son was diagnosed with autism).    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced NEURALGIA (Severe nerve pain in left hip and left lower abdomen.) and PAIN (Felt like deep burning pain). At the time of the report, NEURALGIA (Severe nerve pain in left hip and left lower abdomen.) and PAIN (Felt like deep burning pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication use was reported.  No treatment information was reported.
This spontaneous report as received from a 85 year old female consumer refers to herself with underactive thyroid, arthritis and allergy to penicillin (rash). The patient's medical history included frequent canker sores. On an unknown date in February 2008 the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route not reported) for shingles vaccination. Concomitant therapies included meloxicam and TOPROL. The patient suffered from frequent canker sores before she received ZOSTAVAX. After she received ZOSTAVAX her canker sores temporarily went away but the patient developed her first one since the vaccine in September 2013. No lab diagnostics studies performed. Unspecified medical attention was given for treatment. The patient sought medical attention via spoke with unspecified physician. The outcome of the event was reported as not recovered. Additional information is not expected.
pt recvd vax & 5 days p/vax exp stiffness in rt inj arm, shoulder, & neck some numbness & sl edema on same arm;also h/a, dizziness, diarrhea & not sleeping well;pt examined by neurologist who found some paresthesia
¨still has severe pain¨; ¨Headache¨; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (¨still has severe pain¨) and HEADACHE (¨Headache¨) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, the patient experienced MYALGIA (¨still has severe pain¨) and HEADACHE (¨Headache¨). At the time of the report, MYALGIA (¨still has severe pain¨) and HEADACHE (¨Headache¨) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided by reporter. Treatment information was not provided.
Suspected Vaccination failure; got a severe case of shingles; Very painful; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for herself/himself. The age at vaccination was not reported. The patient stated that, no more vaccine, he/she got a severe case of shingles 3 months later .  No kind of pain medication took by patient, but very painful.  The patient stated that, hope he/she did not get it again.  The doctor tried to talk to patient into getting the new vaccine, he/she said hell no. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule and laboratory confirmation for shingles were not provided.
Hot; feeling sick; Red; Swollen/slisghtly swelling/ big bump; Hard mass; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot), MALAISE (feeling sick), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE SWELLING (Swollen/slisghtly swelling/ big bump) and VACCINATION SITE INDURATION (Hard mass) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis, Depression and Cholesterol.    On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Hot), MALAISE (feeling sick), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE SWELLING (Swollen/slisghtly swelling/ big bump) and VACCINATION SITE INDURATION (Hard mass). At the time of the report, VACCINATION SITE WARMTH (Hot), MALAISE (feeling sick), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE SWELLING (Swollen/slisghtly swelling/ big bump) and VACCINATION SITE INDURATION (Hard mass) outcome was unknown.            Concomitant products included supplement for osteoporosis, antidepressants and medication for cholesterol. On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-067584 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067584:
Patients under 18 years of age got a booster dose from Moderna; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patients under 18 years of age got a booster dose from Moderna) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060H21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine and Pfizer vaccine. Past adverse reactions to the above products included No adverse event with Pfizer vaccine and Pfizer vaccine.    On 08-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 08-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patients under 18 years of age got a booster dose from Moderna). On 08-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patients under 18 years of age got a booster dose from Moderna) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided. No treatment information were provided.
About 16 hours later I had a heart attack, 20% plaque and the rest was a blood clot that acute  my artery. I was in the Hospital for two days. I ended up having angioplasty and a stent. When I went home I had post heart attack issues and a sore arm for about 3 weeks.
Information has been received from a health professional concerning a 9 year old female with an unknown medical history who on 04FEB1997 was vaccinated with a dose of varicella virus vaccine live. It was unknown if the patient was on concomitant medication. ON 02APR2003 the patient was seen in the office with a "very mild case of chicken pox". No lab or diagnostic studies were performed It was also reported that there had been a serious outbreak of chicken pox in local schools. Unspecified medical attention was sought. It was also noted that three other patients, two of whom are siblings of the above mentioned patient, were vaccinated with a dose of varicella virus vaccine live and developed chicken pox.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 27-JUN-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J000495 and expiry date: 14-APR-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Broke out in hives. Have had hives off and on ever since. If takes Benadryl and Zyrtec daily then hives gone but come back if miss a dose. No other prior issues or problems with hives before. Been to dermatologist who said just continue Benadryl and Zyrtec for a few weeks.
24FEB2021 - Moderna Dose 2 27MAR2021- Tetanus  MAR2021 - APR2021 Observation:  Signifiant hair loss, inflamed scalp, hair texture change from smooth to frayed.  Also, sole of feet have spongy feel (tingling, numbness).    Summer 2021 Observation:  Noticed tightness in fingers when clenching fingers, especially when first waking in morning.  More noticeable on right hand.  Symptoms continue to present.   AUG2021:  Prescribed Clobetasol Solution for scalp condition (LPP).  Solution calmed scalp; then, noticed burning sensation, sometimes frostbite sensation, in feet at night.  Spongy with tingling and numbness sensation continue.   Continue with acupuncture with no noticeable improvement.
Less than 24 hours after the vaccine I had numbness on the lower left side of my lip.  I woke up with it like that. Everything functioned fine. It just tingled. On 9/5/2022, it started with heavy congestion in my sinus's, headache and a fever of 102, lots of fatigue, and light sensitivity. On 9/5/2022 COVID-19 home test- and the result was negative. The very next morning on 9/6/2022, the COVID-19 home test was positive.  The symptoms continued to be the same. I called the doctor through tele visit on 9/6/2022, and he prescribed Paxlovid. I still remained sick after taking the 5 days of Paxlovid. After taking the Paxlovid for 5 days, within 2 days of taking the paxlovid all the symptoms came back with a vengeance. The fever, headache, light sensitivity, and fatigue and nausea. I was sick for a total of 19 days. I would not recommend to anyone the Paxlovid.
Swelling in pain in axilla of left arm beginning the day after injection and lasting 3 days
Muscle aches in quads where muscles were previously sore Overall muscle depletion  Loss of balance Nausea Concussion symptoms Felt drunk Headaches from temples to back of head(the pain does not connect in the middle) Shortness of breath Delayed reaction time Felt like I couldn?t move fast enough when I was driving Sweating  Depth perception is off Increased heart rate Unable to focus quickly
About 5:30 PM patient was complaining of a sore throat and headache. By the time she went to bed at 10:00 PM it had worsened but included body aches. At 5:10 AM on 8/4/2016 she woke up with a headache, chills, body ache, sore throat, upset stomach and a 101 fever. Gave her Motrin which helped a bit and she was able to go back to sleep a few hours later. She was down all day and evening with the same symptoms. When she woke up on 8/5/2016 her condition greatly improved and she felt back to normal.
pt recvd flu vax & 1 to 2 wks later began to exp tingling in fingers & toes, & flu-like sx; pt devel difficulty walking; pt hospitalized in ICU 21OCT92; presently has quadriplegia; tx w/plasmapheresis; ventilatory support has not been req;
Twenty four hours following vaccine, ct. having severe headache, T 102.3, pain shooting down left arm & left leg.